Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07852273 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study will focus on the commonly used non-nutritive sweetener (NNS) sucralose (2 sachets/day resulting in daily dose: sucralose 2.5mg/kg) and its role in changing the gut microbiota in humans with Inflammatory Bowel Disease (IBD), compared to healthy non-IBD individuals. We will focus on studying IBD patients affected with Crohn's Disease (CD) as a proof of principle that could be tested later in other IBD subtypes (ulcerative colitis or others specific surgical conditions).
Trial Details
NCT Number NCT07852273
Lead Sponsor Case Western Reserve University
Collaborators: Crohn's and Colitis Foundation
Conditions
(from sponsor)		 Inflamatory Bowel Disease, Crohn Disease (CD)
Related terms Crohn Disease, Inflammatory Bowel Diseases
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov